IRTC Stock Recent News
IRTC LATEST HEADLINES
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President and CEO Brice Bobzien - CFO Conference Call Participants Allen Gong - JPMorgan Malgorzata Kaczor - William Blair Richard Newitter - Truist Marie Thibault - BTIG Joanne Wuensch - Citibank Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo David Rescott - Baird Bill Plovanic - Canaccord Suraj Kalia - Oppenheimer Operator Hello, and welcome to the iRhythm Technologies, Inc. Q1 2024 Earnings Conference Call. My name is Terry, and I will be the conference operator today.
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IRhythm Technologies (IRTC) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.67 per share a year ago.
SAN FRANCISCO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference.
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President & Chief Executive Officer Brice Bobzien - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan Malgorzata Kaczor - William Blair David Saxon - Needham Nathan Treybeck - Wells Fargo John Young - Canaccord David Rescott - Baird Suraj Kalia - Oppenheimer Operator Hello and welcome to the iRhythm Technologies Inc. Q3 2023 Earnings Conference Call. My name is Alex, I'll be coordinating the call today.
The heavy selling pressure might have exhausted for iRhythm Technologies (IRTC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2023 after the close of trading on Thursday, November 2, 2023. The company's management team will host a corresponding conference call beginning at 1:30 p.m.
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the Company will be participating in the upcoming Baird 2023 Global Healthcare Conference and the Morgan Stanley 21st Annual Global Healthcare Conference.